US2011009457A1PendingUtilityA1
Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasistes
Est. expiryDec 21, 2027(~1.4 yrs left)· nominal 20-yr term from priority
A61P 33/00A61P 31/14A61P 33/06A61P 33/14A61P 33/12A61P 31/20A61P 31/04A61P 33/10A61P 31/12A61P 25/00A61P 29/00A61P 17/04A61P 19/00A01N 43/56C07C 2601/10A01N 43/40A01N 43/10C07C 323/62A01N 43/08C07C 237/42C07C 317/44C07D 213/60A61K 31/495A01N 47/20A01N 43/82C07C 2601/16C07C 271/28A01N 37/46A61K 31/53
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a composition comprising at least one aminobenzamide compound or a salt thereof for controlling animal parasites, veterinary pharmaceutical compositions comprising at least one aminobenzamide of formula (I) for preventing infection with diseases transmitted through parasites, its use for the preparation of a veterinary pharmaceutical for controlling animal parasites, and a method for preventing infection with diseases transmitted through parasites.
Claims
exact text as granted — not AI-modified1 . Aminobenzamide derivative of formula (I), or a salt thereof
wherein
A 1 , A 2 , A 3 and A 4 each represent independent from each other C—X, N or N═O;
X represents independent from each other a hydrogen atom, a halogen atom, a hydroxy group, a C 1 -C 6 alkyl group or a trifluoromethyl group;
B 1 and B 2 each represent independent from each other an oxygen atom or a sulfur atom;
R 1 and R 2 respectively represent independent from each other a hydrogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylcarbonyl group, a C 1 -C 6 haloalkylcarbonyl group; or represents a phenyl group or a benzyl group optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen; or pyridyl, pyrazolyl, thienyl, furyl, isoxazolyl, thiadiazolyl or pyridylmethyl, pyrazolylmethyl, thienylmethyl, furylmethyl, isoxazolylmethyl, or thiadiazolylmethyl optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen;
Q represents L or Y—R 6
with
Y representing oxygen, sulfur, amino, C 1 -C 4 aminoalkyl; and
R 6 representing a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 haloalkenyl group, a C 2 -C 6 allynyl group, a C 2 -C 6 haloalkynyl group, a C 3 -C8 cycloalkyl group or a C 3 -C8 halocycloalkyl group; or
-E 1 -Z 1 —R 7 (wherein E 1 represents a C 1 -C 4 alkylene group, a C 2 -C 4 alkenylene group, a C 3 -C 4 alkynylene group, a C 1 -C 4 haloalkylene group, a C 2 -C 4 haloalkenylene group or a C 3 -C 4 haloalkynylene group, R 7 represents a hydrogen atom, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 alkynyl group, a C 1 -C 6 haloalkyl group, a C 2 -C 6 haloalkenyl group or a C 2 -C 6 haloalkynyl group, and Z 1 represents —O—, —S—, —SO—, —SO 2 —, —C(═O)—, —C(═O)O—, —OC(═O)—, —N(R 8 )—, —C(═O)N(R 8 )— or —N(R 8 )C(═O)—); or
-E 2 —R 9 (wherein E 2 represents a C 1 -C 4 alkylene group, a C 2 -C 4 alkenylene group, a C 3 -C 4 alkenylene group, a C 1 -C 4 haloalkylene group, a C 2 -C 4 haloalkenylene group or a C 3 -C 4 haloalkynylene group; and R 9 represents a C 3 -C 8 cycloalkyl group, a C 3 -C 8 halocycloalkyl group, a cyano group, a nitro group, a hydroxy group, a phenyl group, or a substituted phenyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylsulfinyl group, a C 1 -C 6 haloalkylsulfinyl group, a C 1 -C 6 alkylsulfonyl group, a C 1 -C 6 haloalkylsulfonyl group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 haloalkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group and a C 1 -C 4 alkoxycarbonyl group, or a pyridyl group, or a substituted pyridyl group having one or more substituents which are selected from a halogen atom, a C 1 -C 6 haloalkyl group and a C 1 -C 6 haloalkoxy group, a thienyl group or a tetrahydrofuran group);
L represents a phenyl group; or
a heterocyclyl group; or
hydrogen, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 alkynyl group, a C 3 -C 8 cycloalkyl group, a C 3 -C 8 cycloalkenyl group, a C 1 -C 6 aldehyd group, a C 1 -C 6 iminoaldehyd group, a C 1 -C 6 alkoxyiminoaldehyd group, a C 1 -C 6 alkoxyimino-C 1 -C 6 -alkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylsulfinyl group, and a C 1 -C 6 alkylsulfonyl group;
wherein the above-mentioned residues are each optionally substituted with a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group, a C 1 -C 4 alkylamino group, a di-C 1 -C 4 alkylamino group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group, a C 1 -C 4 alkoxycarbonyl group, an acetylamino group, a phenyl group, and a pyridyl group;
W represents a phenyl group, or a substituted phenyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, C 1 -C 4 haloalkyl C 1 -C 4 alkoxy group, C 1 -C 4 haloalkyl C 1 -C 4 haloalkoxy group, a C 1 -C 4 alkoxy group, a C 1 -C 4 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group, a cyano group, a carbony-C 1 -C 4 -alkyl group, a carbony-C 1 -C 4 -haloalkyl group; or a SF 5 group;
for preventing infection with diseases transmitted through parasites.
2 . Aminobenzamide derivative of formula (I-1), or a salt thereof
X represents a hydrogen atom, a halogen atom, a hydroxy group, a C 1 -C 6 alkyl group or a trifluoromethyl group;
R 1 represents a hydrogen atom, a C 1 -C 6 alkyl group a C 1 -C 6 haloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylcarbonyl group, a C 1 -C 6 haloalkylcarbonyl group or represents phenyl or benzyl optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen; or pyridyl, pyrazolyl, thienyl, furyl, isoxazolyl, thiadiazolyl or pyridylmethyl, pyrazolylmethyl, thienylmethyl, furylmethyl, isoxazolylmethyl, or thiadiazolylmethyl optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen
R 3 and R 5 represents independent from each other a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxy group, a C 1 -C 4 haloalkoxy group, C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group or a cyano group;
R 4 represents C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, C 1 -C 4 haloalkyl C 1 -C 4 alkoxy group, C 1 -C 4 haloalkyl C 1 -C 4 haloalkoxy group, a C 1 -C 4 alkoxy group, a C 1 -C 4 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group or a SF 5 group;
L represents a phenyl group, or a substituted phenyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group, a C 1 -C 4 alkylamino group, a di-C 1 -C 4 alkylamino group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group, a C 1 -C 4 alkoxycarbonyl group, an acetylamino group and a phenyl group; or a pyridyl group; or a pyridyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group, a C 1 -C 4 alkylamino group, a di-C 1 -C 4 alkylamino group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group, a C 1 -C 4 alkoxycarbonyl group, an acetylamino group and a phenyl group; or
hydrogen, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group and a C 1 -C 3 haloalkylsulfonyl group; or
a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 -alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group and a C 1 -C 3 haloalkylsulfonyl group, each substituted with phenyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 2 -C 4 alkenyl group, a C 2 -C 4 haloalkenyl group, a C 2 -C 4 alkynyl group, a C 2 -C 4 haloalkynyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 3 alkoxy group, a C 1 -C 3 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group, a C 1 -C 4 alkylamino group, a di-C 1 -C 4 alkylamino group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group, a C 1 -C 4 alkoxycarbonyl group, an acetylamino group and a phenyl group; or a pyridyl
for preventing infection with diseases transmitted through parasites.
3 . Aminobenzamide derivative of formula (I-2), or a salt thereof
X represents a hydrogen atom, a halogen atom, a hydroxy group, a C 1 -C 3 alkyl group or a trifluoromethyl group;
Y represents oxygen, sulfur, amino, C 1 -C 4 aminoalkyl;
R 1 represents a hydrogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylcarbonyl group, a C 1 -C 6 haloalkylcarbonyl group; or represents a phenyl group or a benzyl group optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen; or pyridyl, pyrazolyl, thienyl, furyl, isoxazolyl, thiadiazolyl or pyridylmethyl, pyrazolylmethyl, thienylmethyl, furylmethyl, isoxazolylmethyl, or thiadiazolylmethyl optionally substituted with at least one group selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkylthio, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 haloalkylsulfonyl, nitro, hydroxy, and halogen;
R 3 and R 5 represents independent from each other a halogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, a C 1 -C 4 alkoxy group, a C 1 -C 4 haloalkoxy group, C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group or a cyano group;
R 4 represents C 1 -C 4 alkyl group, a C 1 -C 4 haloalkyl group, C 1 -C 4 haloalkyl C 1 -C 4 alkoxy group, C 1 -C 4 haloalkyl C 1 -C 4 haloalkoxy group, a C 1 -C 4 alkoxy group, a C 1 -C 4 haloalkoxy group, a C 1 -C 3 alkylthio group, a C 1 -C 3 haloalkylthio group, a C 1 -C 3 alkylsulfinyl group, a C 1 -C 3 haloalkylsulfinyl group, a C 1 -C 3 alkylsulfonyl group, a C 1 -C 3 haloalkylsulfonyl group or a SF 5 group;
R 6 representing a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 haloalkenyl group, a C 2 -C 6 alkynyl group, a C 2 -C 6 haloalkynyl group, a C 3 -C8 cycloalkyl group or a C 3 -C8 halocycloalkyl group; or
-E 1 -Z 1 —R 7 (wherein E 1 represents a C 1 -C 4 alkylene group, a C 2 -C 4 alkenylene group, a C 3 -C 4 alkynylene group, a C 1 -C 4 haloalkylene group, a C 2 -C 4 haloalkenylene group or a C 3 -C 4 haloalkynylene group, R 7 represents a hydrogen atom, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 alkynyl group, a C 1 -C 6 haloalkyl group, a C 2 -C 6 haloalkenyl group or a C 2 -C 6 haloalkynyl group, and Z 1 represents —O—, —S—, —SO—, —SO 2 —, —C(═O)—, —C(═O)O—, —OC(═O)—, —N(R 8 )—, —C(═O)N(R 8 )— or —N(R 8 )C(═O)—); or
-E 2 —R 9 (wherein E 2 represents a C 1 -C 4 alkylene group, a C 2 -C 4 alkenylene group, a C 3 -C 4 alkynylene group, a C 1 -C 4 haloalkylene group, a C 2 -C 4 haloalkenylene group or a C 3 -C 4 haloalkynylene group; and R 9 represents a C 3 -C 8 cycloalkyl group, a C 3 -C 8 halocycloalkyl group, a cyano group, a nitro group, a hydroxy group, a phenyl group, or a substituted phenyl group having one or more substituents which may be the same or different and which are selected from a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylsulfinyl group, a C 1 -C 6 haloalkylsulfinyl group, a C 1 -C 6 alkylsulfonyl group, a C 1 -C 6 haloalkylsulfonyl group, a cyano group, a nitro group, a hydroxy group, a C 1 -C 4 alkylcarbonyl group, a C 1 -C 4 haloalkylcarbonyl group, a C 1 -C 4 alkylcarbonyloxy group and a C 1 -C 4 alkoxycarbonyl group, or a pyridyl group, or a substituted pyridyl group having one or more substituents which are selected from a halogen atom, a C 1 -C 6 haloalkyl group and a C 1 -C 6 haloalkoxy group, a thienyl group or a tetrahydrofuran group);
for preventing infection with diseases transmitted through parasites.
4 . Pharmaceutical composition, comprising at least one aminobenzamide derivative of formulas (I), (I-1) or (I-2), or a salt thereof for preventing infection with diseases transmitted through parasites.
5 . Use of the aminobenzamide derivative as defined in any of claims 1 to 3 or of a composition as defined in claim 4 for controlling parasites.
6 . Use of the aminobenzamide derivative as defined in any of claims 1 to 3 for the preparation of a composition for controlling parasites.
7 . Use according to claim 6 wherein the parasites are acari.
8 . Use according to claim 7 wherein the acari are selected from the group: Amblyomma americanum, Dermacentor variabilis, Dermacentor reticulatus, Rhipicephalus sanguineus, Rhipicephalus decoloratus.
9 . Aminobenzamide derivative as defined in any of claims 1 to 3 for the use in controlling parasites.Join the waitlist — get patent alerts
Track US2011009457A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.